Member Info for L2analyst

43p about to go

Gulf states got plenty of money and they want to diversify, a nice rns tommrrow morning and that will be the last time we see 40s, and 50s,

Hoping for 50p today if not 45p be ok for now

Its rising on news no doubt otherwise it wouldnt go up a penny

I was loading at 120, 100, 80p so still long way to go

That 150k is definitely a buy!

Shame ig dont allow to open new position

Its just recoverying, need £1 plus

I hope they dont put out rns of no reason

Mm gobbled up 46k shares at a fantastic price, it goes to show these slimes know more then us

Just added under 3k at 40.48

Would you be want to out? It's worth many times current mcap, shorts would be burning

As previously announced, the Board of Imutex is exploring strategic alternatives with regards to both assets, including but not limited to a full sale, a licensing agreement or a non-dilutive funding arrangement with a collaborator to run the Phase III development and study for the FLU-v vaccine candidate. Any material information regarding discussions or about the Imutex assets will be announced as appropriate.

FLU-v - Strong FLU-v data package around a first-in-class 'universal', broad spectrum, standalone, flu vaccine candidate -- Positive results from the Phase IIb Field (FLU-v 003) and Challenge studies (FLU-v 004) -- Management believe FLU-v is now able to advance into Phase III development -- Further data analysis and full and final results of FLU-v 004 to be published by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH), in due course -- Publication of the FLU-v 003 full results by Universal Influenza Vaccines Secured Consortium (UNISEC) in due course AGS-v - Universal mosquito-borne diseases vaccine candidate -- Results of the AGS-v Phase I first-in-man study conducted at NIAID expected by end 2018 As previously announced, the Board of Imutex is exploring strategic alternatives with regards to both assets, including but not limited to a full sale, a licensing agreement or a non-dilutive funding arrangement with a collaborator to run the Phase III development and study for the FLU-v vaccine candidate. Any material information regarding discussions or about the Imutex assets will be announced as appropriate.

Someone paid 41p over the askung price

My take is gulf state oman is either a partner or providing all funds, just my opinion

There goes 40

45p either today or tomorrow so that is very short target indeed

Buys flooding in

Addicknt are you back in? I need £1 a share